European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

Sandra J J Kooij, Susanne Bejerot, Andrew Blackwell, Herve Caci, Miquel Casas-Brugué, Pieter J Carpentier, Dan Edvinsson, John Fayyad, Karin Foeken, Michael Fitzgerald, Veronique Gaillac, Ylva Ginsberg, Chantal Henry, Johanna Krause, Michael B Lensing, Iris Manor, Helmut Niederhofer, Carlos Nunes-Filipe, Martin D Ohlmeier, Pierre Oswald, Stefano Pallanti, Artemios Pehlivanidis, Josep A Ramos-Quiroga, Maria Rastam, Doris Ryffel-Rawak, Steven Stes, Philip Asherson, Sandra J J Kooij, Susanne Bejerot, Andrew Blackwell, Herve Caci, Miquel Casas-Brugué, Pieter J Carpentier, Dan Edvinsson, John Fayyad, Karin Foeken, Michael Fitzgerald, Veronique Gaillac, Ylva Ginsberg, Chantal Henry, Johanna Krause, Michael B Lensing, Iris Manor, Helmut Niederhofer, Carlos Nunes-Filipe, Martin D Ohlmeier, Pierre Oswald, Stefano Pallanti, Artemios Pehlivanidis, Josep A Ramos-Quiroga, Maria Rastam, Doris Ryffel-Rawak, Steven Stes, Philip Asherson

Abstract

Background: Attention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe.

Methods: The European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe. This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated.

Results: Besides information on the genetics and neurobiology of ADHD, three major questions are addressed in this statement: (1) What is the clinical picture of ADHD in adults? (2) How can ADHD in adults be properly diagnosed? (3) How should ADHD in adults be effectively treated?

Conclusions: ADHD often presents as an impairing lifelong condition in adults, yet it is currently underdiagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group.

References

    1. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153(9):1143–1146.
    1. Wood DR, Reimherr FW, Wender PH, Johnson GE. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976;33(12):1453–1460.
    1. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, Demytteneare K, de Girolamo G, Haro JM, Jin R. et al.Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009;65(1):46–54. doi: 10.1016/j.biopsych.2008.10.005.
    1. Lie N. Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature. Acta Psychiatr Scand Suppl. 1992;368:1–40. doi: 10.1111/j.1600-0447.1992.tb10575.x.
    1. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry. 1985;42(10):937–947.
    1. Weiss G, Hechtman L, Milroy T. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry. 1985;24:211–220. doi: 10.1016/S0002-7138(09)60450-7.
    1. Mannuzza S, Klein RG, Addalli KA. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1991;30(5):743–751. doi: 10.1097/00004583-199109000-00008.
    1. Mannuzza S, Klein RG, Bessler A, Malloy P. et al.Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50(7):565–576.
    1. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279–289. doi: 10.1037/0021-843X.111.2.279.
    1. Mannuzza S, Klein RG, Moulton JL. Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies? J Atten Disord. 2003;7(2):93–100. doi: 10.1177/108705470300700203.
    1. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39(11):1424–1431. doi: 10.1097/00004583-200011000-00017.
    1. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165. doi: 10.1017/S003329170500471X.
    1. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816–818. doi: 10.1176/appi.ajp.157.5.816.
    1. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35(9):1213–1226. doi: 10.1097/00004583-199609000-00019.
    1. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35(3):343–351. doi: 10.1097/00004583-199603000-00016.
    1. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204–211. doi: 10.1192/bjp.bp.107.048827.
    1. Kooij JJS, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CAT, Hodiamont PPG. Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817–827. doi: 10.1017/S003329170400337X.
    1. Kessler RC, Adler LE, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, Ustun TB. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47(6):565–572. doi: 10.1097/01.jom.0000166863.33541.39.
    1. Fayyad J, de Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C. et al.Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409. doi: 10.1192/bjp.bp.106.034389.
    1. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic epidemiology. 2000;18(1):1–16. doi: 10.1002/(SICI)1098-2272(200001)18:1<1::AID-GEPI1>;2-X.
    1. Faraone SV, Doyle AE, Knoerzer JA. Heritability of attention-deficit/hyperactivity disorder. Economics of Neuroscience. 2001;3(5):54–57.
    1. Kessler RC. Comorbidity patterns in a community sample of adults with ADHD: results from the National Comorbidity Survey Replication. APA 160th Annual Meeting. 2007.
    1. Mancini C, Van Ameringen M, Oakman J, Figueiredo D. Childhood attention deficit/hyperactivity disorder in adults with anxiety disorders. Psychol Med. 1999;29(3):515–525. doi: 10.1017/S0033291798007697.
    1. Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000;58(2):99–106.
    1. Alpert JE, Maddocks A, Nierenberg AA, O'Sullivan R, Pava JA, Worthington JJ, Biederman J, Rosenbaum JF, Fava M. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996;62(3):213–219. doi: 10.1016/0165-1781(96)02912-5.
    1. Fossati A, Novella L, Donati D, Donini M, Maffei C. History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. ComprPsychiatry. 2002;43(5):369–377.
    1. Goossensen M, van de Glind G, Carpentier P-J, Wijsen RM, van Duin D, Kooij J. An intervention program for ADHD in patients with substance use disorders: Preliminary results of a field trial. J Subst Abuse Treat. 2006;30(3):253–259. doi: 10.1016/j.jsat.2005.12.004.
    1. Foreman DM, Foreman D, Prendergast M, Minty B. Is clinic prevalence of ICD-10 hyperkinesis underestimated? Impact of increasing awareness by a questionnaire screen in an UK clinic. Eur Child Adolesc Psychiatry. 2001;10(2):130–134.
    1. Weiss M, Hechtman L, Weiss G. ADHD in parents. JAmAcadChild AdolescPsychiatry. 2000;39(8):1059–1061.
    1. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol. 2000;68(5):830–842. doi: 10.1037/0022-006X.68.5.830.
    1. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T. et al.Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194(3):273–277. doi: 10.1192/bjp.bp.107.045245.
    1. NICE. Attention Deficit Hyperactivity Disorder: The NICE guideline on diagnosis and managment of ADHD in children, young people and adults. The British Psychological Society and The Royal College of Psychiatrists; 2008.
    1. Ebert D, Krause J, Roth-Sackenheim C. ADHD in adulthood - guidelines based on expert consensus with DGPPN support (German) Nervenarzt. 2003;74(939):946.
    1. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E. et al.Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007;21(1):10–41. doi: 10.1177/0269881106073219.
    1. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann NY Acad Sci. 2001;931:1–16. doi: 10.1111/j.1749-6632.2001.tb05770.x.
    1. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol. 1995;23(6):729–749.
    1. Kooij JJS, Aeckerlin LP, Buitelaar JK. Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a Psychiatric Outpatients' Department. [Dutch] Nederlands Tijdschrift voor Geneeskunde. 2001;145(31):1498–1501.
    1. Fischer M, Barkley RA, Smallish L, Fletcher K. Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity. Dev Neuropsychol. 2005;27(1):107–133. doi: 10.1207/s15326942dn2701_5.
    1. Brown TE. Brown Attention-Deficit Disorder Scales. Manual. San Antonio: The Psychological Corporation; 1996.
    1. Buitelaar JK. [Discussion of attention deficit-hyperactivity disorder (ADHD): facts, opinions and emotions] Ned Tijdschr Geneeskd. 2001;145(31):1485–1489.
    1. Biederman J, Faraone SV, Spencer T, Wilens T. et al.Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(12):1792–1798.
    1. Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm. 2003;9(5):416–423.
    1. Asherson P, Chen W, Craddock B, Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry. 2007;190:4–5. doi: 10.1192/bjp.bp.106.026484.
    1. Pescosolido BA, Jensen PS, Martin JK, Perry BL, Olafsdottir S, Fettes D. Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children. J Am Acad Child Adolesc Psychiatry. 2008;47(3):339–349. doi: 10.1097/CHI.0b013e318160e3a0.
    1. Lanham JS. The evaluation of attention deficit/hyperactivity disorder in family medicine residency programs. South Med J. 2006;99(8):802–805. doi: 10.1097/01.smj.0000215738.43515.c7.
    1. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2001;10(2):299–292ix.
    1. Faraone SV. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27:303–321.
    1. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323. doi: 10.1016/j.biopsych.2004.11.024.
    1. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39(11):1432–1437. doi: 10.1097/00004583-200011000-00018.
    1. Moore J, Fombonne E. Psychopathology in adopted and nonadopted children: a clinical sample. Am J Orthopsychiatry. 1999;69(3):403–409. doi: 10.1037/h0080415.
    1. Gilger JW, Pennington BF, DeFries JC. A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia. J Am Acad Child Adolesc Psychiatry. 1992;31(2):343–348.
    1. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):745–753.
    1. Rietveld MJ, Hudziak JJ, Bartels MvB. CE. Boomsma DI. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry. 2004;45(3):577–588. doi: 10.1111/j.1469-7610.2004.00247.x.
    1. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997;36(6):737–744. doi: 10.1097/00004583-199706000-00009.
    1. Stevens SE, Sonuga-Barke EJ, Kreppner JM, Beckett C, Castle J, Colvert E, Groothues C, Hawkins A, Rutter M. Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence. J Abnorm Child Psychol. 2008;36(3):385–398. doi: 10.1007/s10802-007-9185-5.
    1. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323. doi: 10.1016/j.biopsych.2004.11.024.
    1. Kuntsi J, Rijsdijk F, Ronald A, Asherson P, Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol Psychiatry. 2005;57(6):647–654. doi: 10.1016/j.biopsych.2004.12.032.
    1. Larsson JO, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43(10):1267–1275. doi: 10.1097/.
    1. van den Berg SM, Willemsen G, de Geus EJ, Boomsma DI. Genetic etiology of stability of attention problems in young adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(1):55–60. doi: 10.1002/ajmg.b.30251.
    1. Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ. et al.Genet epidemiol of attention deficit hyperactivity disorder (ADHD index) in adults. PloS one. 2010;5(5):e10621. doi: 10.1371/journal.pone.0010621.
    1. Halperin JM, Schulz KP. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychological bulletin. 2006;132(4):560–581. doi: 10.1037/0033-2909.132.4.560.
    1. Halperin JM, Trampush JW, Miller CJ, Marks DJ, Newcorn JH. Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. Journal of child psychology and psychiatry, and allied disciplines. 2008;49(9):958–966. doi: 10.1111/j.1469-7610.2008.01926.x.
    1. Kuntsi J, Wood AC, Rijsdijk F, Johnson KA, Andreou P, Albrecht B, Arias Vasquez A, Buitelaar J, McLoughlin G, Rommelse N, Seperation of cognitive impairments in attention deficit hyperactivity disorder into two familial factors. Arch Gen Psychiatry. 2010. in press .
    1. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) Human molecular genetics. 2006;15(14):2276–2284. doi: 10.1093/hmg/ddl152.
    1. Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct. 2006;2:27. doi: 10.1186/1744-9081-2-27.
    1. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Human genetics. 2009;126(1):13–50. doi: 10.1007/s00439-009-0663-4.
    1. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ. et al.Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1576–1579. doi: 10.1002/ajmg.b.30861.
    1. Johansson S, Halmoy A, Mavroconstanti T, Jacobsen KK, Landaas ET, Reif A, Jacob C, Boreatti-Hummer A, Kreiker S, Lesch KP. et al.Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(5):1008–15.
    1. Landaas ET, Johansson S, Jacobsen KK, Ribases M, Bosch R, Sanchez-Mora C, Jacob CP, Boreatti-Hummer A, Kreiker S, Lesch KP. et international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes, brain, and behavior. 2010;9(5):449–58.
    1. Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, Bosch R, Boreatti-Hummer A, Heine M, Jacob CP, Lesch KP, Fasmer OB, Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet. pp. 512–523.
    1. Ribases M, Hervas A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, Fernandez-Anguiano M, Nogueira M, Gomez-Barros N, Valero S. et al.Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63(10):935–945. doi: 10.1016/j.biopsych.2007.11.004.
    1. Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M. et al.Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular psychiatry. 2009;14(1):71–85. doi: 10.1038/sj.mp.4002100.
    1. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007;96(9):1269–1274. doi: 10.1111/j.1651-2227.2007.00430.x.
    1. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings. Am J Addict. 1997;6(3):205–217.
    1. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene-environment interaction. Biol Psychiatry. 1997;41(1):65–75. doi: 10.1016/0006-3223(95)00653-2.
    1. Botting N, Powls A, Cooke RW, Marlow N. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry. 1997;38(8):931–941. doi: 10.1111/j.1469-7610.1997.tb01612.x.
    1. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry. 2009;66(8):722–727. doi: 10.1016/j.biopsych.2009.05.032.
    1. Bekker EM, Overtoom CC, Kenemans JL, Kooij JJ, De Noord I, Buitelaar JK, Verbaten MN. Stopping and changing in adults with ADHD. Psychol Med. 2005;35(6):807–816. doi: 10.1017/S0033291704003459.
    1. Bekker EM, Kenemans JL, Hoeksma MR, Talsma D, Verbaten MN. The pure electrophysiology of stopping. International Journal of Psychophysiology. 2005;55(2):191–8. doi: 10.1016/j.ijpsycho.2004.07.005.
    1. Seidman LJ, Valera EM, Bush G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):323–347. doi: 10.1016/j.psc.2004.01.002.
    1. Seidman LJ, Doyle A, Fried R, Valera E, Crum K, Matthews L. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):261–282. doi: 10.1016/j.psc.2003.12.005.
    1. Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1263–1272. doi: 10.1016/j.biopsych.2004.11.019.
    1. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2008;8(4):611–625. doi: 10.1586/14737175.8.4.611.
    1. Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord. 2002;6(Suppl 1):S7–16.
    1. Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neuroscience & Biobehavioral Reviews. 2003;27(7):605–613.
    1. Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry. 2007;62(9):1059–1061. doi: 10.1016/j.biopsych.2006.12.008.
    1. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB. et al.Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46(8):1015–1027. doi: 10.1097/chi.0b013e3180686d7e.
    1. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM. et al.Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage. 2007;34(3):1182–1190. doi: 10.1016/j.neuroimage.2006.10.014.
    1. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel D, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M. et al.Dorsolateral Prefrontal and Anterior Cingulate Cortex Volumetric Abnormalities in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Magnetic Resonance Imaging. Biol Psychiatry. 2006;60(10):1071–1080. doi: 10.1016/j.biopsych.2006.04.031.
    1. Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361–1369. doi: 10.1016/j.biopsych.2006.06.011.
    1. Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ. Cortical Thinning of the Attention and Executive Function Networks in Adults with Attention-Deficit/Hyperactivity Disorder. Cerebral Cortex. 2007;17(6):1364–1375. doi: 10.1093/cercor/bhl047.
    1. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N. et al.Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1996;53(7):607–616.
    1. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, Vaituzis AC, Blumenthal JD, Nelson J, Bastain TM. et al.Quantitative brain magnetic resonance imaging in girls with attention- deficit/hyperactivity disorder. ArchGenPsychiatry. 2001;58(3):289–295.
    1. Castellanos FX. Anatomic magnetic resonance imaging studies of attention-deficit/hyperactivity disorder. Dialogues in Clinical Neuroscience. 2002;4(4):444–448.
    1. Semrud-Clikeman M, Filipek PA, Biederman J, Steingard R, Kennedy D, Renshaw P, Bekken K. Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry. 1994;33(6):875–881. doi: 10.1097/00004583-199407000-00014.
    1. Durston S, Pol HE, Schnack HG, Buitelaar JK, Steenhuis MP, Minderaa RB, Kahn RS, van Engeland H. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. Child & Adolescent Social Work Journal. 2004;21(1):332–340.
    1. Durston S. Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics? Dev Psychopathol. 2008;20(4):1133–1143. doi: 10.1017/S0954579408000539.
    1. Makris N, Buka SL, Biederman J, Papadimitriou GM, Hodge SM, Valera EM, Brown AB, Bush G, Monuteaux MC, Caviness VS. et al.Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex. 2008;18(5):1210–1220. doi: 10.1093/cercor/bhm156.
    1. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry. 1999;45(12):1542–1552. doi: 10.1016/S0006-3223(99)00083-9.
    1. Suskauer SJ, Simmonds DJ, Fotedar S, Blankner JG, Pekar JJ, Denckla MB, Mostofsky SH. Functional magnetic resonance imaging evidence for abnormalities in response selection in attention deficit hyperactivity disorder: differences in activation associated with response inhibition but not habitual motor response. J Cogn Neurosci. 2008;20(3):478–493. doi: 10.1162/jocn.2008.20032.
    1. Paloyelis Y, Mehta MA, Kuntsi J, Asherson P. Functional MRI in ADHD: a systematic literature review. Expert review of neurotherapeutics. 2007;7(10):1337–1356. doi: 10.1586/14737175.7.10.1337.
    1. Pliszka SR, Glahn DC, Semrud-Clikeman M, Franklin C, Perez R, Xiong J, Liotti M. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. The Am J Psychiatry. 2006;163(6):1052–1060. doi: 10.1176/appi.ajp.163.6.1052.
    1. Rubia K, Smith AB, Brammer MJ, Toone B, Taylor E. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. The Am J Psychiatry. 2005;162(6):1067–1075. doi: 10.1176/appi.ajp.162.6.1067.
    1. Zametkin AJ, Nordahl TE, Gross M, King A. et al.Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine. 1990;323(20):1361–1366. doi: 10.1056/NEJM199011153232001.
    1. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. ArchGenPsychiatry. 1993;50(5):333–340.
    1. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci. 1998;18(15):5901–5907.
    1. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB. Striatal dysfunction in attention deficit and hyperkinetic disorder. Archives of Neurology. 1989;46(1):48–52.
    1. Amen DG, Hanks C, Prunella J. Preliminary evidence differentiating ADHD using brain SPECT imaging in older patients. J Psychoactive Drugs. 2008;40(2):139–146.
    1. Wilens TE, Decker MW. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognition. Biochem Pharmacol. 2007;7:7.
    1. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2002;5(2):111–113. doi: 10.1017/S1461145702002821.
    1. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y. et al.Evaluating dopamine reward pathway in ADHD: clinical implications. Jama. 2009;302(10):1084–1091. doi: 10.1001/jama.2009.1308.
    1. APA. Washington DC. 4 1994. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. .
    1. Tripp G, Luk SL, Schaughency EA, Singh R. DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder. JAmAcadChild AdolescPsychiatry. 1999;38(2):156–164.
    1. Faraone SV, Sergeant J, Gillberg C. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2:104–113.
    1. Lee SI, Schachar RJ, Chen SX, Ornstein TJ, Charach A, Barr C, Ickowicz A. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. J Child Psychol Psychiatry. 2008;49(1):70–78. doi: 10.1111/j.1469-7610.2007.01784.x.
    1. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert review of neurotherapeutics. 2005;5(4):525–539. doi: 10.1586/14737175.5.4.525.
    1. Kooij JJS. ADHD in adults. Clinical studies on assessment and treatment. Radboud University Nijmegen; 2006.
    1. Skirrow C, McLoughlin G, Kuntsi J, Asherson P. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert review of neurotherapeutics. 2009;9(4):489–503. doi: 10.1586/ern.09.2.
    1. Biederman J, Petty CR, Fried R, Kaiser R, Dolan CR, Schoenfeld S, Doyle AE, Seidman LJ, Faraone SV. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2008;69(8):1217–1222. doi: 10.4088/JCP.v69n0803.
    1. de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, Borges G, Demyttenaere K, Gasquet I, de Girolamo G. et al.The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008;65(12):835–842. doi: 10.1136/oem.2007.038448.
    1. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. ComprPsychiatry. 1996;37(6):393–401.
    1. Barkley R, Gordon M. In: Clinicians' guide to adult ADHD: Assessment and intervention. Goldstein S, Ellison AT, editor. San Diego, CA: Academic Press, Inc; 2002. Research on comorbidity, adaptive functioning, and cognitive impairments in adults with ADHD: Implications for a clinical practice; pp. 43–69. full_text.
    1. Robin LA. The impact of ADHD on marriage. The ADHD Report. 2002;10(3):9–14. doi: 10.1521/adhd.10.3.9.20553.
    1. Fischer M, Barkley RA, Smallish L, Fletcher K. Hyperactive children as young adults: Driving abilities, safe driving behavior, and adverse driving outcomes. Accident; Analysis and Prevention. 2007;39(1):94–105. doi: 10.1016/j.aap.2006.06.008.
    1. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics. 1996;98(6 Pt 1):1089–1095.
    1. Barkley RA, Murphy KR, Dupaul GJ, Bush T. Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsychological Society. 2002;8(5):655–672. doi: 10.1017/S1355617702801345.
    1. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113–128. doi: 10.1016/j.jsr.2006.09.004.
    1. Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health. 2004;35(4):346–349. e341.
    1. Van Veen MM, Kooij JJS, Boonstra AM, Gordijn M, Van Someren EJW. Disrupted circadian rhythm in adults with ADHD and chronic sleep onset insomnia. Biol Psychiatry. 2009;67(11):1091–1096.
    1. Gau SS, Kessler RC, Tseng WL, Wu YY, Chiu YN, Yeh CB, Hwu HG. Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults. Sleep. 2007;30(2):195–201.
    1. Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(Suppl 12):10–15.
    1. Ohlmeier MD, Peters K, Kordon A, Seifert J, Wildt BT, Wiese B, Ziegenbein M, Emrich HM, Schneider U. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD) Alcohol and alcoholism (Oxford, Oxfordshire) 2007;42(6):539–543. doi: 10.1093/alcalc/agm069.
    1. Young S, Gudjonsson G, Wells J, Asherson P, Theobald J, Oliver B, Scott C, Mooney A. Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population Personality and Individual Differences. 2009. pp. 265–269.
    1. Mannuzza S, Klein RG, Moulton JL. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res. 2008;160(3):237–246. doi: 10.1016/j.psychres.2007.11.003.
    1. Foley HA, Carlton CO, Howell RJ. The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications. Bull Am Acad Psychiatry Law. 1996;24(3):333–345.
    1. Ziegler E, Blocher D, Bro J, Rosler M. Assessment of attention deficit hyperactivity disorder (ADHD) in prison inmates. [German] Recht & Psychiatrie. 2003;21(1):17–21.
    1. Young S, Gudjonsson G, Ball S, Lam J. Attention Deficit Hyperactivity Disorder (ADHD) in personality disordered offenders and the association with disruptive behavioural problems. Journal of Forensic Psychiatry & Psychology. 2003;14(3):491–505.
    1. Minde K, Eakin L, Hechtman L, Ochs E, Bouffard R, Greenfield B, Looper K. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry. 2003;44(4):637–646. doi: 10.1111/1469-7610.00150.
    1. Weiss G, Hechtman L. Hyperactive children grown up. ADHD in children, adolescents and adults. 2. New York: Guilford Press; 1993.
    1. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. JAmAcadChild AdolescPsychiatry. 1997;36(9):1222–1227.
    1. Kessler RC, Lane M, Stang PE, Van Brunt DL, Trott GE. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med. 2008;21(1):1–11.
    1. Antshel KM, Faraone SV, Maglione K, Doyle A, Fried R, Seidman L, Biederman J. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ? Psychol Med. 2008;24:1–11.
    1. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child AdolescPsychiatrClinNAm. 2000;9(3):711–726.
    1. Murphy KR, Barkley RA, Bush T. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history. J Nerv Ment Dis. 2002;190(3):147–157. doi: 10.1097/00005053-200203000-00003.
    1. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564–577.
    1. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Jama: Journal of the American Medical Association. 1998;279(14):1100–1107. doi: 10.1001/jama.279.14.1100.
    1. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998;59(Suppl 7):50–58.
    1. Kooij JJS, Burger H, Boonstra AM, van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med. 2004;34(6):973–982. doi: 10.1017/S0033291703001776.
    1. Shekim WO, Asarnow RF, Hess E, Zaucha K. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Comprehensive Psychiatry. 1990;31(5):416–425. doi: 10.1016/0010-440X(90)90026-O.
    1. Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2004;65(Suppl 3):3–7.
    1. Rasmussen K, Almvik R, Levander S. Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population. J Am Acad Psychiatry Law. 2001;29(2):186–193.
    1. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. AmJPsychiatry. 1998;155(4):493–498.
    1. Wilens TE, Prince JB, Biederman J, Spencer TJ, Frances RJ. Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults. Psychiatr Serv. 1995;46(8):761–763. 765.
    1. Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry. 2007;68(Suppl 11):4–8.
    1. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7(2):156–163.
    1. Wilens TE, Hahesy AL, Biederman J, Bredin E, Tanguay S, Kwon A, Faraone SV. Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Am J Addict. 2005;14(2):179–187. doi: 10.1080/10550490590924872.
    1. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C. et al.Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409. doi: 10.1192/bjp.bp.106.034389.
    1. Breyer JL, Botzet AM, Winters KC, Stinchfield RD, August G, Realmuto G. Young Adult Gambling Behaviors and their Relationship with the Persistence of ADHD. J Gambl Stud. 2009;13:13.
    1. Arnold LE. Sex differences in ADHD: conference summary. JAbnormChild Psychol. 1996;24(5):555–569.
    1. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994;53(1):13–29. doi: 10.1016/0165-1781(94)90092-2.
    1. Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry. 2004;55(7):692–700. doi: 10.1016/j.biopsych.2003.12.003.
    1. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159(1):36–42. doi: 10.1176/appi.ajp.159.1.36.
    1. Kessler RC, Adler L, Berkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K. et al.The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723. doi: 10.1176/appi.ajp.163.4.716.
    1. Taylor EW, Keltner NL. Messy purse girls: Adult females and ADHD. Perspectives in Psychiatric Care. 2002;38(2):69–72. doi: 10.1111/j.1744-6163.2002.tb00659.x.
    1. Dopfner M, Pluck J, Berner W, Fegert JM, Huss M, Lenz K, Schmeck K, Lehmkuhl U, Poustka F, Lehmkuhl G. Mental disturbances in children and adolescents in Germany. Results of a representative study:age,gender and rater effects. Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie. 1997;25(4):218–233.
    1. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL. et al.Symptom profiles in children with ADHD: effects of comorbidity and gender. JAmAcadChild AdolescPsychiatry. 2001;40(2):137–146.
    1. Nadeau KG, Quinn PO. Understanding women with AD/HD. Silver Spring: Advantage Books; 2002.
    1. Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ, Weber W, Jetton J, Kraus I, Pert J. et al.Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry. 1999;38(8):966–975. doi: 10.1097/00004583-199908000-00012.
    1. Judd F, Komiti A, Jackson H. How does being female assist help-seeking for mental health problems? Aust N Z J Psychiatry. 2008;42(1):24–29. doi: 10.1080/00048670701732681.
    1. Kooij JJS, Boonstra AM, Willemsen-Swinkels SHN, Bekker EM, Noord Id, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report regarding symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adult patients. Journal of Attention Disorders. 2008;11(4):445–458. doi: 10.1177/1087054707299367.
    1. Brown TE, (Ed) Attention-deficit disorders and comorbidities in children, adolescents, and adults. Washington, DC: American Psychiatric Publishing, Inc; 2000.
    1. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, McBurnett K. et al.Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1211–1221. doi: 10.1097/00004583-199709000-00013.
    1. Barkley RA. In: Attention deficit hyperactivity disorder: State of the science-best practices. Jensen Peter S, Cooper James R, editor. Civic Research Institute, Kington, New Jersey.; 2002. ADHD--Long-term course, adult outcome, and comorbid disorders.
    1. Barkley RA. Age dependent decline in ADHD: True recovery or statistical illusion? The ADHD Report. 1997;5:1–5.
    1. Brown TE. Executive functions and attention deficit hyperactivity disorder: Implications of two conflicting views. Internationalo Journal of Disability, Development and Education. 2006;53(1):35–46. doi: 10.1080/10349120500510024.
    1. Barkley R, Murphy KR, Fischer M. ADHD in adults: what the science says. New York: Guilford Press; 2007.
    1. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2000;157(7):1156–1159.
    1. Zucker M, Morris MK, Ingram SM, Morris RD, Bakeman R. Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess. 2002;14(4):379–389. doi: 10.1037/1040-3590.14.4.379.
    1. Danckaerts M, Heptinstall E, Chadwick O, Taylor E. Self-report of attention deficit and hyperactivity disorder in adolescents. Psychopathology. 1999;32(2):81–92. doi: 10.1159/000029071.
    1. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007;11(2):106–113. doi: 10.1177/1087054707300094.
    1. Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D. Attention deficit hyperactivity disorder in adults - early vs. late onset in a retrospective study. Psychiatry Res. 2003;119:217–223. doi: 10.1016/S0165-1781(03)00105-7.
    1. Karam RG, Bau CH, Salgado CA, Kalil KL, Victor MM, Sousa NO, Vitola ES, Picon FA, Zeni GD, Rohde LA. et al.Late-onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res. 2009;43(7):697–701. doi: 10.1016/j.jpsychires.2008.10.001.
    1. Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med. 2009;39(4):685–693. doi: 10.1017/S0033291708003917.
    1. Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA. Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder? J Clin Psychiatry. 2007;68(7):1109–1116. doi: 10.4088/JCP.v68n0720.
    1. Faraone SV, Biederman J, Doyle A, Murray K, Petty C, Adamson JJ, Seidman L. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;60(10):1081–1087. doi: 10.1016/j.biopsych.2006.03.060.
    1. Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, Adamson JJ, Monuteaux MC. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006;163(10):1720–1729. doi: 10.1176/appi.ajp.163.10.1720.
    1. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, Tannock R, Castellanos FX. The age at onset of attention deficit hyperactivity disorder. The Am J Psychiatry. pp. 14–16.
    1. Willoughby MT, Curran PJ, Costello EJ, Angold A. Implications of early versus late onset of attention-deficit/hyperactivity disorder symptoms. Journal of the American Academy of Child & Adolescent Psychiatry. 2000;39(12):1512–1519.
    1. Todd RD, Huang H, Henderson CA. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11. J Child Psychol Psychiatry. 2008;49(9):942–949. doi: 10.1111/j.1469-7610.2008.01892.x.
    1. Barkley RA, Murphy KR, Fischer M. ADHD in adults. What the science says. New York: The Guilford Press; 2007.
    1. Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1204–1210. doi: 10.1097/00004583-199709000-00012.
    1. Antshel KM. Attention-Deficit Hyperactivity Disorder in the context of a high intellectual quotient/giftedness. Dev Disabil Res Rev. 2008;14(4):293–299. doi: 10.1002/ddrr.34.
    1. Chen W, Zhou K, Sham P, Franke B, Kuntsi J, Campbell D, Fleischman K, Knight J, Andreou P, Arnold R. et al.DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1450–1460. doi: 10.1002/ajmg.b.30672.
    1. Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. The Am J Psychiatry. 1995;152(3):431–435.
    1. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. Journal of child psychology and psychiatry, and allied disciplines. 2008;49(5):535–542. doi: 10.1111/j.1469-7610.2007.01857.x.
    1. Willcutt EG, Pennington BF, Olson RK, DeFries JC. Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(6):709–714. doi: 10.1002/ajmg.b.30310.
    1. Francks C, Fisher SE, Marlow AJ, MacPhie IL, Taylor KE, Richardson AJ, Stein JF, Monaco AP. Familial and genetic effects on motor coordination, laterality, and reading-related cognition. The Am J Psychiatry. 2003;160(11):1970–1977. doi: 10.1176/appi.ajp.160.11.1970.
    1. Landgren M, Pettersson R, Kjellman B, Gillberg C. ADHD, DAMP and other neurodevelopmental/psychiatric disorders in 6-year- old children: epidemiology and co-morbidity. Dev Med Child Neurol. 1996;38(10):891–906.
    1. Gillberg C. Deficits in attention, motor control, and perception: a brief review. Arch Dis Child. 2003;88(10):904–910. doi: 10.1136/adc.88.10.904.
    1. Upadhyaya HP. Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician. Primary care companion to the Journal of clinical psychiatry. 2008;10(3):211–221. doi: 10.4088/PCC.v10n0306.
    1. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J. et al.Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. The Am J Psychiatry. 2007;164(4):674–677. doi: 10.1176/appi.ajp.164.4.674.
    1. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci. 2006;256(Suppl 1):i26–31. doi: 10.1007/s00406-006-1004-4.
    1. Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences. 2001;931:251–270. doi: 10.1111/j.1749-6632.2001.tb05783.x.
    1. Modestin J, Matutat B, Wurmle O. Antecedents of opioid dependence and personality disorder: attention-deficit/hyperactivity disorder and conduct disorder. Eur Arch Psychiatry Clin Neurosci. 2001;251(1):42–47. doi: 10.1007/s004060170067.
    1. Ohlmeier MD, Peters K, Te Wildt BT, Zedler M, Ziegenbein M, Wiese B, Emrich HM, Schneider U. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD) Alcohol and alcoholism (Oxford, Oxfordshire) 2008;43(3):300–304. doi: 10.1093/alcalc/agn014.
    1. Wilson JJ, Levin FR. Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Curr Psychiatry Rep. 2001;3(6):497–506. doi: 10.1007/s11920-001-0044-8.
    1. Wilens TE, Upadhyaya HP, Faraone SV, Biederman J. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry. 2007;68(8):e20. doi: 10.4088/JCP.0807e20.
    1. Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ. An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. J Subst Abuse Treat. 2006;30(3):253–259. doi: 10.1016/j.jsat.2005.12.004.
    1. Flory K, Lynam DR. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play? Clin Child Fam Psychol Rev. 2003;6(1):1–16. doi: 10.1023/A:1022260221570.
    1. Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and alcohol dependence. 2004;73(1):87–97. doi: 10.1016/j.drugalcdep.2003.10.004.
    1. Kolpe M, Carlson GA. Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict. 2007;16(1):46–48. doi: 10.1080/10601330601080073.
    1. Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. The Journal of clinical psychiatry. 2007;68(Suppl 11):15–22.
    1. Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. The Am J Psychiatry. 2006;163(12):2059–2063. doi: 10.1176/appi.ajp.163.12.2059.
    1. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV. Checklists, Norms and Clinical Interpretation. New York: The Guilford Press; 1998.
    1. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Scnik K, Spencer T. et al.The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256. doi: 10.1017/S0033291704002892.
    1. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T. et al.The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256. doi: 10.1017/S0033291704002892.
    1. Daigre C, Ramos-Quiroga JA, Valero S, Bosch R, Roncero C, Gonzalvo B, Nogueira M, Casas M. Adult ADHD Self-Report Scale (ASRS-v1.1) symptoms checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2009;6(37):299–305.
    1. Conners CK, Erhardt D, Sparrow E. Conners Adult ADHD Rating Scales (CAARS). Technical Manual. New York: Multi Health Systems Inc; 1999.
    1. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885–890.
    1. Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci. 2006;256(Suppl 1):i3–i11. doi: 10.1007/s00406-006-1001-7.
    1. Epstein JN, Johnson DE, Conners CK. CAADID. The Conner's Adult ADHD Diagnostic Interview for DSM-IV. MHS Inc; 2001.
    1. Diagnostisch Interview voor ADHD (DIVA) bij volwassenen.
    1. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. Executive functioning in adult ADHD: a meta-analytic review. PsycholMed. 2005.
    1. Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry. 2006;7(3):152. doi: 10.1080/15622970500518444.
    1. Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol. 2006;23(5):440–455.
    1. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005;57(3):229–238. doi: 10.1016/j.biopsych.2004.11.009.
    1. McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins T, Sahakian B. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol Med. 2004;34(4):681–692. doi: 10.1017/S0033291703001296.
    1. Liotti M, Pliszka SR, Perez R, Luus B, Glahn D, Semrud-Clikeman M. Electrophysiological correlates of response inhibition in children and adolescents with ADHD: influence of gender, age, and previous treatment history. Psychophysiology. 2007;44(6):936–948. doi: 10.1111/j.1469-8986.2007.00568.x.
    1. Kuntsi J, McLoughlin G, Asherson P. Attention deficit hyperactivity disorder. Neuromolecular Med. 2006;8(4):461–484. doi: 10.1385/NMM:8:4:461.
    1. Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol. 2010;25(3):157–173. doi: 10.1093/arclin/acq014.
    1. Barkley RA, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. Journal of the American Academy of Child and Adolescent Psychiatry. 2010;49(5):503–513. doi: 10.1097/00004583-201005000-00011.
    1. Golubchik P, Sever J, Zalsman G, Weizman A. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol. 2008;23(4):228–231. doi: 10.1097/YIC.0b013e3282f94ae2.
    1. Hooberman D, Stern TA. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report. J Clin Psychiatry. 1984;45(10):441–442.
    1. Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93–101. doi: 10.4088/JCP.v68n0113.
    1. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009;31:31.
    1. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol. 2009;23(7):733–744. doi: 10.1177/0269881108092338.
    1. Meszaros A, Czobor P, Balint S, Komlosi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(8):1137–1147.
    1. Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr ClinNAm. 2006;15(1):13–50.
    1. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004;13(Suppl 1):I102–116.
    1. Young S, Amarasinghe J. Practioner review: Non-pharmacological treatments for ADHD: A lifespan perspective. Journal of Child Psychology and Psychiatry. 2009. in press .
    1. Safren SA. Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry. 2006;67(Suppl 8):46–50.
    1. Ramsay JR. Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2007;9(5):427–433. doi: 10.1007/s11920-007-0056-0.
    1. Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Medicine. 2007;37(1):1–11. doi: 10.1017/S0033291706008713.
    1. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524–540. doi: 10.4088/JCP.v67n0403.
    1. Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry. 2006;60(1):38–43. doi: 10.1080/08039480500520665.
    1. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996;37(6):393–401. doi: 10.1016/S0010-440X(96)90022-X.
    1. Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008;120(3):27–38. doi: 10.3810/pgm.2008.09.1905.
    1. Murphy K. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. J Clin Psychol. 2005;61(5):607–619. doi: 10.1002/jclp.20123.
    1. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36(1):21–29. doi: 10.1097/00004583-199701000-00013.
    1. Faraone SV, Biederman J, Wilens TE, Adamson J. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med. 2007;37(12):1743–1752. doi: 10.1017/S0033291707000335.
    1. Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? J Child Adolesc Psychopharmacol. 2005;15(5):787–798. doi: 10.1089/cap.2005.15.787.
    1. Wilens TE. Does the medicating ADHD increase or decrease the risk for later substance abuse? Rev Bras Psiquiatr. 2003;25(3):127–128. doi: 10.1590/S1516-44462003000300001.
    1. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20. doi: 10.1542/peds.104.2.e20.
    1. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1):179–185. doi: 10.1542/peds.111.1.179.
    1. Kalbag AS, Levin FR. Adult ADHD and substance abuse: diagnostic and treatment issues. Substance use & misuse. 2005;40(13-14):1955–1981. 2043-1958.
    1. Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict. 2007;16(Suppl 1):45–54. doi: 10.1080/10550490601082783. quiz 55-46.
    1. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160(11):1909–1918. doi: 10.1176/appi.ajp.160.11.1909.
    1. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage. 2008;39(3):1266–1273. doi: 10.1016/j.neuroimage.2007.09.059.
    1. Faraone SV, Upadhyaya HP. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion. J Clin Psychiatry. 2007;68(11):e28. doi: 10.4088/JCP.1107e28.
    1. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A. et al.Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006;15(8):476–495. doi: 10.1007/s00787-006-0549-0.
    1. Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44–50. doi: 10.1097/JCP.0b013e318192e4a0.
    1. Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57(7):793–801.
    1. Turner D. A review of the use of modafinil for attention-deficit hyperactivity disorder. Expert Rev Neurother. 2006;6(4):455–468. doi: 10.1586/14737175.6.4.455.
    1. Kendall T, Taylor E, Perez A, Taylor C. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. Bmj. 2008;337(337):a1239. doi: 10.1136/bmj.a1239.
    1. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–835. doi: 10.1016/j.biopsych.2005.09.011.
    1. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004;7(1):77–97. doi: 10.1017/S1461145703003973.
    1. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456–463. doi: 10.1016/j.biopsych.2004.11.043.
    1. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):120–129. doi: 10.1007/s00406-008-0845-4.
    1. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2003;48(8):546–554.
    1. Wilens TE, Spencer TJ. The stimulants revisited. Child AdolescPsychiatrClinNAm. 2000;9(3):573–603. viii.
    1. Tossell JW, Greenstein DK, Davidson AL, Job SB, Gochman P, Lenane M, Nugent Iii TF, Gogtay N, Sporn AL, Rapoport JL. Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series. Journal of child and adolescent psychopharmacology. 2004;14(3):448–454. doi: 10.1089/cap.2004.14.448.
    1. Nickels K, Katusic SK, Colligan RC, Weaver AL, Voigt RG, Barbaresi WJ. Stimulant medication treatment of target behaviors in children with autism: a population-based study. J Dev Behav Pediatr. 2008;29(2):75–81. doi: 10.1097/DBP.0b013e31815f24f7.
    1. Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y. et al.Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007;61(4):538–544. doi: 10.1016/j.biopsych.2006.09.028.
    1. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child: care, health and development. 2006;32(5):575–583. doi: 10.1111/j.1365-2214.2006.00631.x.
    1. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11):1266–1274. doi: 10.1001/archpsyc.62.11.1266.
    1. Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2009;48(9):884–893. doi: 10.1097/CHI.0b013e3181b26e9f.
    1. Poncin Y, Sukhodolsky DG, McGuire J, Scahill L. Drug and non-drug treatments of children with ADHD and tic disorders. European child & adolescent psychiatry. 2007;16(Suppl 1):78–88.
    1. Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Seminars in neurology. 2008;28(3):379–388. doi: 10.1055/s-2008-1079342.
    1. Ashton H, Gallagher P, Moore B. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol. 2006;20(5):602–610. doi: 10.1177/0269881106061710.
    1. Kollins SH. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry. 2003;64(Suppl 11):14–18.
    1. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Lieberman J, Hitzemann R. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995;52(6):456–463.
    1. Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. Journal of the American Board of Family Practice. 2004;17(4):235–239. doi: 10.3122/jabfm.17.4.235.
    1. Larriviere D, Williams MA, Rizzo M, Bonnie RJ. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology. 2009;73(17):1406–1412. doi: 10.1212/WNL.0b013e3181beecfe.
    1. Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs. 2005;19(8):643–655. doi: 10.2165/00023210-200519080-00001.
    1. Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM. et al.Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96(1-2):145–154. doi: 10.1016/j.drugalcdep.2008.02.009.
    1. Adler LA. Pharmacotherapy for adult ADHD. J Clin Psychiatry. 2009;70(5):e12. doi: 10.4088/JCP.7129br5c.
    1. Madaan V. Lisdexamfetamine dimesylate for childhood ADHD. Drugs Today (Barc) 2008;44(5):319–324. doi: 10.1358/dot.2008.44.5.1215724.
    1. Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625–639.
    1. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. JAmAcadChild AdolescPsychiatry. 1997;36(6):754–763.
    1. Garland EJ. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. JPsychopharmacol. 1998;12(4):385–395. doi: 10.1177/026988119801200410.
    1. Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gomez N, Yelmo S, Ferrer M, Martinez Y, Casas M. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs. 2008;22(7):603–611. doi: 10.2165/00023210-200822070-00005.
    1. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord. 2009;12(5):449–459. doi: 10.1177/1087054708320397.
    1. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt SJ. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct. 2005;1:16. doi: 10.1186/1744-9081-1-16.
    1. Kollins SH, Wilens TE, Fusillo S, Faraone SV, Upadhyaya HP. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord. 2008;12(2):115–125. doi: 10.1177/1087054707311654.
    1. Jasinski DR, Faries DE, Moore RJ, Schuh LM, Allen AJ. Abuse liability assessment of atomoxetine in a drug-abusing population. Drug Alcohol Depend. 2008;95(1-2):140–146. doi: 10.1016/j.drugalcdep.2008.01.008.
    1. Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, West SA, Soni P. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry. 2005;58(2):125–131. doi: 10.1016/j.biopsych.2005.04.040.
    1. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212–221. doi: 10.1002/da.20549.
    1. Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008;13(12):1047–1055.
    1. Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED. Bupropion SR in adults with ADHD: A short-term, placebo-controlled trial. Neuropsychiatric Disease And Treatment. 2005;1(3):245–251.
    1. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC. et al.A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. AmJPsychiatry. 2001;158(2):282–288.
    1. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153(9):1147–1153.
    1. Popper CW. Antidepressants in the treatment of attention-deficit/hyperactivity disorder. JClinPsychiatry. 1997;58(Suppl 14):14–29.
    1. Adler LA, Reingold LS, Morrill MS, Wilens TE. Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep. 2006;8(5):409–415. doi: 10.1007/s11920-006-0044-9.
    1. Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clinical pharmacokinetics. 2001;40(10):753–772. doi: 10.2165/00003088-200140100-00004.
    1. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. 2007;6(21):21. doi: 10.1186/1476-511X-6-21.
    1. Nadeau KG. In: A comprehensive guide to attention deficit disorder in adults: Research, diagnosis, and treatment. Nadeau KG, editor. Philadelphia, PA: Brunner/Mazel, Inc; 1995. Life management skills for the adult with ADD; pp. 191–217.
    1. Nadeau KG. In: A comprehensive guide to attention deficit disorder in adults: Research, diagnosis, and treatment. Nadeau KG, editor. Philadelphia, PA: Brunner/Mazel, Inc; 1995. ADD in the workplace: Career consultation and counseling for the adult with ADD; pp. 308–334.
    1. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy. 2005;43(7):831–842. doi: 10.1016/j.brat.2004.07.001.
    1. Aim B. Psychotherapy of attention deficit hyperactivity disorder in adults. Nervenheilkunde: Zeitschrift fur interdisziplinaere Fortbildung. 2006;25(6):459–464.
    1. Weiss M, Safren SA, Solanto MV, Hechtman L, Rostain AL, Ramsay JR, Murray C. Research forum on psychological treatment of adults with ADHD. J Atten Disord. 2008;11(6):642–651. doi: 10.1177/1087054708315063.
    1. Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434–441. doi: 10.1177/1087054708314596.
    1. O'Connell RG, Bellgrove MA, Dockree PM, Robertson IH. Cognitive remediation in ADHD: effects of periodic non-contingent alerts on sustained attention to response. Neuropsychological rehabilitation. 2006;16(6):653–665. doi: 10.1080/09602010500200250.
    1. Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. Journal of child psychology and psychiatry, and allied disciplines. 2009;50(7):780–789. doi: 10.1111/j.1469-7610.2008.02033.x.
    1. Butnik SM. Neurofeedback in adolescents and adults with attention deficit hyperactivity disorder. J Clin Psychol. 2005;61(5):621–625. doi: 10.1002/jclp.20124.
    1. Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlstrom K, Gillberg CG, Forssberg H, Westerberg H. Computerized training of working memory in children with ADHD--a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry. 2005;44(2):177–186. doi: 10.1097/00004583-200502000-00010.
    1. Arns M, de Ridder S, Strehl U, Breteler M, Coenen A. Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci. 2009;40(3):180–189.
    1. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of Meta-Cognitive Therapy for Adult ADHD. The Am J Psychiatry. 2010;167(8):958–68. doi: 10.1176/appi.ajp.2009.09081123.
    1. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med. 2002;156(5):504–511.
    1. Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005;21(2):195–206. doi: 10.1185/030079904X20303.
    1. Bernfort L, Nordfeldt S, Persson J. ADHD from a socio-economic perspective. Acta Paediatr. 2008;97(2):239–245. doi: 10.1111/j.1651-2227.2007.00611.x.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する